Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Chugai Pharmaceutical(CHGCY) the Revenue is 2.109 B (+5.29%), Beat estimate;the EBIT is 993.57 M (+5.22%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
2.11B5.29%
2.10B4.88%
+0.01B0.41%
EBITMiss expectations
0.99B5.22%
1.05B11.46%
-0.06B6.24%
Upcoming earnings report - Q3 FY2026
Available dateOct 27, 2026
Estimate Revenue$2.26 B
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf